{"id":"https://openalex.org/W1878097091","doi":null,"title":"Alogliptin: New Addition to Existing Gliptins for the Management of Type-2 Diabetes Mellitus","display_name":"Alogliptin: New Addition to Existing Gliptins for the Management of Type-2 Diabetes Mellitus","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1878097091","mag":"1878097091"},"language":"en","primary_location":{"id":"mag:1878097091","doi":null,"is_oa":false,"landing_page_url":"http://www.rjps.in/sites/default/files/rjps-3-1-2013-1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210210392","display_name":"Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences","issn_l":"2249-2208","issn":["2249-2208"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"RGUHS Journal of Pharmaceutical Sciences","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085387912","display_name":"Pitchai Balakumar","orcid":"https://orcid.org/0000-0003-1940-1296","observed_orcids":["https://orcid.org/0000-0003-1940-1296"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pitchai Balakumar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1940-1296","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5085387912"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2037,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57697575,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9409999847412109},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7590000033378601},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.6909999847412109},{"id":"https://openalex.org/keywords/glucagon","display_name":"glucagon","score":0.7229999899864197},{"id":"https://openalex.org/keywords/diabetes-prevalence","display_name":"diabetes prevalence","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.8089452981948853},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7484469413757324},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.7010139226913452},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6825584173202515},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5279219150543213},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.48185858130455017},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.42609208822250366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38097327947616577},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32159584760665894},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.16200315952301025},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.10731247067451477}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1878097091","doi":null,"is_oa":false,"landing_page_url":"http://www.rjps.in/sites/default/files/rjps-3-1-2013-1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210210392","display_name":"Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences","issn_l":"2249-2208","issn":["2249-2208"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"RGUHS Journal of Pharmaceutical Sciences","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1569365382","https://openalex.org/W1966128342","https://openalex.org/W1986044732","https://openalex.org/W1993019100","https://openalex.org/W1994187226","https://openalex.org/W1998324755","https://openalex.org/W2002978401","https://openalex.org/W2016632734","https://openalex.org/W2027479466","https://openalex.org/W2027788348","https://openalex.org/W2035474792","https://openalex.org/W2039410214","https://openalex.org/W2044362480","https://openalex.org/W2059245135","https://openalex.org/W2059903872","https://openalex.org/W2082354988","https://openalex.org/W2084762332","https://openalex.org/W2092918268","https://openalex.org/W2104053168","https://openalex.org/W2106154942","https://openalex.org/W2135424573","https://openalex.org/W2137911781","https://openalex.org/W2149832640","https://openalex.org/W2151668968","https://openalex.org/W2168626372"],"related_works":["https://openalex.org/W2001576661","https://openalex.org/W1984293537","https://openalex.org/W2922665864","https://openalex.org/W2145945287","https://openalex.org/W7095123294","https://openalex.org/W2313653615","https://openalex.org/W2245503723","https://openalex.org/W4410745260","https://openalex.org/W7095682534","https://openalex.org/W2728884349"],"abstract_inverted_index":{"Address":[0],"for":[1],"correspondence":[2],"Pitchai":[3],"Balakumar,":[4],"PhD":[5],"Associate":[6],"Professor,":[7],"Pharmacology":[8],"Unit":[9],"Faculty":[10],"of":[11,38,55,90,107,109,130],"Pharmacy":[12],"AIMST":[13],"University":[14],"Semeling,":[15],"08100":[16],"Bedong":[17],"Kedah":[18],"Darul":[19],"Aman":[20],"Malaysia.":[21],"E-mail:":[22],"pbala2006@gmail.":[23],"com":[24],"Diabetes":[25,95],"mellitus":[26,59,92,96],"represents":[27],"a":[28,105,116],"major":[29],"clinical":[30],"and":[31,43,80],"economic":[32],"burden":[33],"worldwide.":[34],"It":[35],"is":[36,97],"one":[37],"most":[39,44],"common":[40],"insidious":[41],"disorders,":[42],"challenging":[45],"health":[46],"problems":[47],"in":[48,69,83,122],"the":[49,81,123],"21st":[50],"century.":[51],"The":[52],"total":[53],"number":[54],"people":[56],"with":[57],"diabetes":[58,91],"has":[60],"been":[61],"projected":[62],"to":[63,71],"increase":[64],"globally":[65],"from":[66],"366":[67],"million":[68,73],"2011":[70],"552":[72],"by":[74,99],"2030":[75],"(Box":[76],"1).1,2":[77,94],"China,":[78],"India":[79],"USA":[82],"that":[84,126],"order":[85],"have":[86],"high":[87],"prevalence":[88],"rate":[89],"(Table":[93],"characterized":[98],"hyperglycemia,":[100],"which":[101],"mainly":[102],"occurs":[103],"as":[104],"result":[106],"deficiency":[108],"insulin":[110,113],"secretion":[111],"or":[112],"resistance":[114],"although":[115],"few":[117],"more":[118],"factors":[119],"are":[120],"involved":[121],"disease":[124],"pathology":[125],"include":[127],"over":[128],"production":[129],"glucagon,":[131]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}